Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fulengene is a biotechnology company based in Guangzhou, China, that specializes in providing comprehensive molecular biology and genetic engineering services. The company offers a robust suite of solutions including high-throughput gene synthesis, plasmid DNA preparation, and the construction of various viral vectors such as lentivirus, adenovirus, and adeno-associated virus (AAV). Fulengene also provides specialized services in CRISPR/Cas9 gene editing, stable cell line generation, and recombinant protein expression to support global research and drug development efforts. By integrating advanced molecular technologies with industrial-scale production, the company serves as a critical partner for academic institutions and biopharmaceutical companies. Their expertise in viral vector systems makes them a key player in the rapidly growing field of gene and cell therapy development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fulengene.